OriGene Logo

Customer Login

Checkout as a new customer

Creating an account has many benefits:

  • See order and shipping status
  • Track order history
  • Check out faster
Create an Account

TissueScan, Endometrial Cancer cDNA Array I

Be the first to review this product
SKU
EDRT101
48 samples covering 6-normal, 3-Stage IA, 3-IB, 3-IC, 2-IIA, 6-IIB, 12-IIIA, 7-IIIC, 1-IVA, 3-IVB, 2-IV. Available in 2, 5, 10 identical plates.
  $1,060.00
2 Weeks*

Frequently Bought Together (4)

D11-18 Polink-1 HRP Polymer Detection for MOUSE and RABBIT antibodies on human tissue
18 ml
$420.00
D12-6 Polink-1 HRP Polymer Detection for MOUSE antibody on human or animal tissue (non-rodent)
6 ml
$250.00
HP205798 qSTAR qPCR primer pairs against Homo sapiens gene GAPDH 200 reactions
$150.00
MP205604 qSTAR qPCR primer pairs against Mus musculus gene Gapdh 200 reactions
$150.00
Specifications
Specifications
Product Data
TissueScan Type Cancer Specific
Array Name Endometrial Cancer cDNA Array I
Clinical Info
Diagnosis Category Endomentrial Cancer
Tissue Endometrium
Shipping Ambient
Description 48 samples covering 6-normal, 3-Stage IA, 3-IB, 3-IC, 2-IIA, 6-IIB, 12-IIIA, 7-IIIC, 1-IVA, 3-IVB, 2-IV. Available in 2, 5, 10 identical plates.
Reviews
Write Review
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources

file-alt Citations

CIZ1-F, an alternatively spliced variant of the DNA replication protein CIZ1 with distinct expression and localisation, is overrepresented in early stage common solid tumours
Swarts, Stewart, Higgins et al
Cell Cycle (2018) 17 (18), 2268-2283 DOI: 10.1080/15384101.2018.1526600
AI Summary: OriGene's colon cancer cDNA array was used in this study to analyze and compare CIZ1-F and replication domain (CIZ1-RD) expression in primary colon tumors and matched normal samples.
Snippet: (a) CIZ1-F and replication domain (CIZ1-RD) expression in 24 primary colon tumors and matched normal samples (Origene colon cancer cDNA Individual data per case can be found in Figure 4, and individual classifications and pathology notes accesses at www.origene
Receptor Activator of Nuclear Factor Kappa B (RANK) and Clinicopathological Variables in Endometrial Cancer: A Study at Protein and Gene Level
Gómez, Castro, Martínez et al
Int J Mol Sci (2018) 19 (7) DOI: 10.3390/ijms19071848
AI Summary: OriGene’s TissueScan™ cDNA array (catalogue number EDRT305) was used to analyze RANK mRNA levels across endometrial tumor samples of varying grades and stages, enabling the study’s investigation of gene expression in relation to clinicopathological variables.
Snippet: To investigate whether the amount of RANK mRNA was related to prognostic factors of endometrial cancer, a commercially available (catalogue number EDRT305) TissueScanTM cDNA array (TcDA) plate, containing cDNA from endometrial tumors at different histological grades, clinical and TNM stages, was purchased from OriGene (Rockville, MD, USA)
FigureFigureFigure
Hydroxycarboxylic acid receptors are essential for breast cancer cells to control their lipid/fatty acid metabolism
Stäubert, Broom, Nordström
Oncotarget (2015) 6 (23), 19706-20 DOI: 10.18632/oncotarget.3565
Cited by 54
AI Summary: In this study, OriGene’s siRNA products targeting HCA1 and HCA3 were used to knock down these genes in breast cancer cells, helping to demonstrate the essential role of hydroxycarboxylic acid receptors in regulating cancer cell metabolism and survival.
FigureFigureFigure
Repression of endometrial tumor growth by targeting SREBP1 and lipogenesis
Li, Tai, Zhou et al
Cell Cycle (2012) 11 (12), 2348-58 DOI: 10.4161/cc.20811
Cited by 77
AI Summary: OriGene’s TissueScan™ cDNA Arrays were used in this study to analyze lipogenic gene expression in endometrial cancer and normal tissues, enabling the identification of increased SREBP1 target gene expression in cancer cells.
Snippet: Adjacent normal tissues were included for some cancer tissues. Endometrial Cancer cDNA Arrays (TissueScan TM cDNA Arrays) were purchased from OriGene Technologies, Inc. Clinical characteristics, No. of patients, Percentage (%). Age (y): ≤50, 28, 23.14. >50, 93, 76.86.
The Krüppel-like factor 9 (KLF9) network in HEC-1-A endometrial carcinoma cells suggests the carcinogenic potential of dys-regulated KLF9 expression
Simmen, Su, Xiao et al
Reprod Biol Endocrinol (2008) 6, 41 DOI: 10.1186/1477-7827-6-41
Cited by 73
AI Summary: In this study, OriGene products—including the human KLF9 cDNA clone (OriGene, SC118968) and KLF9-specific shRNA plasmid (OriGene, TL314590)—were used to manipulate KLF9 expression levels in HEC-1-A endometrial carcinoma cells, enabling the researchers to investigate the gene networks and cellular pathways regulated by KLF9.
FigureFigureFigure
Showing 1-5 of 5 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products